Editorial Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Mar 19, 2025; 15(3): 99045
Published online Mar 19, 2025. doi: 10.5498/wjp.v15.i3.99045
Integrating behavioral interventions for Tourette’s syndrome: Current status and prospective
Xiao-Man Chen, Shuo Zhang, Department of Neurology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
Michael Xu, Department of Clinical Medicine, International Education School, Shenyang 110004, Liaoning Province, China
ORCID number: Shuo Zhang (0000-0002-4367-0026); Michael Xu (0000-0002-0248-6097).
Author contributions: Zhang S and Chen XM conceived and designed the editorial; Zhang S and Xu M reviewed and edited the manuscript; Zhang S and Chen XM wrote the paper; All of the authors read and approved the final version of the manuscript to be published.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shuo Zhang, MD, PhD, Assistant Professor, Department of Neurology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning Province, China. flybird31025@163.com
Received: July 11, 2024
Revised: December 13, 2024
Accepted: January 2, 2025
Published online: March 19, 2025
Processing time: 229 Days and 5.1 Hours

Abstract

In the evolving landscape of Tourette’s syndrome (TS) treatment, behavioral therapies have emerged as essential to address the comorbid psychological issues, as well as motor and vocal tics. This editorial comments on the study by Wang et al, which showed that cognitive-behavioral therapy (CBT) combined with habit reversal training significantly improved anxiety and tic severity in children with TS. We highlight the current status and future perspectives of behavioral interventions such as CBT, and comprehensive behavioral intervention for tics, demonstrating their efficacy in alleviating TS symptoms and improving patients' quality of life. Recognizing the multifaceted nature of TS, our discussion integrates empirical evidence from various studies to provide a comprehensive perspective on the role of behavioral therapy in the management of this complex condition. This editorial concludes by emphasizing the need for innovative strategies that may address the limitations of existing treatments and advocates a multidisciplinary approach that combines behavioral, pharmacological, and neurobiological interventions to improve outcomes for patients with TS.

Key Words: Tourette's syndrome; Tics; Behavioral therapy; Habit reversal training; Psychological disorders; Comprehensive behavioral intervention for tics; Neurodiversity

Core Tip: Behavioral therapies has unequivocally carved a niche for Tourette's syndrome (TS) management, especially in addressing the psychological comorbidities that often shadow the motor and vocal tics characteristic of the disorder. Through a comprehensive evaluation of Wang et al's study on the combination of cognitive-behavioral therapy and habit reversal training in treating TS, this editorial has illuminated the significant strides made in the field, while simultaneously casting light on the limitations and challenges that persist.



INTRODUCTION

Embedded within the intricate tapestry of neurodevelopmental disorders, Tourette’s syndrome (TS) stands as a unique challenge, characterized by its hallmark motor and vocal tics, coupled with a constellation of comorbid conditions that significantly impact the quality of life of affected individuals. The multifaceted nature of TS, encompassing not only the overt physical manifestations but also the psychological undercurrents such as obsessive-compulsive disorder (OCD), anxiety disorders and depression, underscores the imperative for a comprehensive, multidisciplinary approach to its management.

Recent decades have witnessed a paradigm shift in the therapeutic landscape for TS, with behavioral therapies emerging as a cornerstone in the arsenal against this disorder. These therapies, notably cognitive behavioral therapy (CBT), such as exposure and response prevention (ERP), and comprehensive behavioral intervention for Tics (CBIT), such as habit reversal training (HRT), have garnered considerable attention for their efficacy in mitigating symptoms and enhancing the functional capacity of TS patients[1]. This shift reflects a growing recognition of the psychological dimensions of TS, signaling a departure from a singular focus on pharmacological interventions[2].

The study performed by Wang et al[3] on the application of the CBT combined with HRT in the management of TS has been pivotal. Their findings not only highlighted the importance of behavioral interventions but also provided clinical evidence for the effectiveness of the combination of CBT and HRT in addressing both tics and comorbid psychological conditions. This contribution has been instrumental in shaping the current guidelines for TS treatment and has paved the way for further exploration of behavioral treatment strategies in mitigating the multifaceted challenges of TS. However, a further evaluation and refinement is required for the comprehensive behavioral interventions for TS treatment due to the limitations of the study type, as well as the long-term efficacy and applicability across diverse populations. Moreover, the interplay between genetic, environmental, and neurobiological factors in the pathogenesis of TS beckons for a more nuanced understanding of the condition, one that integrates these dimensions into a holistic treatment framework of behavioral treatment of TS.

THE COMBINATION OF HRT AND CBT IN THE TREATMENT OF TOURETTE'S SYNDROME

HRT has emerged as a cornerstone of CBIT for treating TS, offering a structured approach to managing tics through awareness training and competing response training[2]. Moreover, the efficacy of HRT has been substantiated by a meta-analysis conducted by Yu et al[4], which demonstrated its effectiveness in alleviating tic symptoms.

The groundbreaking study by Wang et al[3] has profoundly influenced the field of behavioral treatment in TS, particularly in addressing the psychological comorbidities prevalent in TS patients. Their research, which delved into the efficacy of CBT combined with HRT for anxiety disorders in children with TS, highlighted a significant gap in existing literature and practice regarding the treatment of anxiety disorders in this population. This gap, previously underexplored, was crucially bridged by Wang et al’s study[3], offering a novel, evidence-based approach to managing anxiety symptoms that often accompany the motor and vocal tics characteristic of TS.

Their findings underscored the potential of the combination modality of CBT and HRT as a synergistic treatment modality, demonstrating a remarkable reduction in anxiety symptoms and tic severity in children with TS. This dual-pronged strategy not only alleviated the primary symptoms of TS but also addressed the psychological distress that often compounds the challenges faced by these children, thereby improving overall treatment adherence and parental satisfaction. The integration of CBT and HRT under the umbrella of CBIT has gained significant traction in recent years[5,6]. The synergistic effect of these therapies underscores the importance of a comprehensive approach that addresses both the physical and psychological dimensions of the disorder, enhancing self-efficacy, and improving social functioning. The study's conclusion, which advocated the integration of CBT and HRT, highlighted the potential of combined behavioral interventions as a significant component in the comprehensive management of TS.

Moreover, the impact of Wang et al's work[3] extends beyond the immediate clinical implications to the broader landscape of behavioral therapy research. It has served as a catalyst for further exploration into the efficacy of behavioral interventions for TS, inspiring subsequent studies to expand upon their findings. The research has led to a shift in patient-centered, multifaceted treatment approaches that acknowledge and address the complex psychosocial dimensions of TS[7]. A closer look at long-term effects of behavioral interventions, personalized treatment approaches, and combining behavioral therapy with other therapeutic modalities, including pharmacological and neurobiological interventions, has been prompted by the study's findings.

LIMITATIONS AND GAPS IN THE STUDY

Although Wang et al[3] made significant contributions to the field of TS management, particularly in demonstrating the efficacy of CBT in conjunction with HRT for anxiety disorders, their research also has several shortcomings and gaps. These limitations call for further for further investigation and innovation in the behavioral therapies for TS patients.

The retrospective study predominantly focused on the short-term outcomes of CBT and HRT in a relatively homogeneous group of children with TS. Moreover, the study type, sample size and demographic characteristics of subjects may limit the generalizability of their findings to broader, more diverse populations of TS patients, including adults and those from different racial and socioeconomic backgrounds. This raises questions about the applicability and effectiveness of the combined behavioral therapy approach across different demographic contexts, suggesting the need for further research to explore the treatment's efficacy in a more representative sample.

Furthermore, the long-term durability of treatment effects represents a crucial aspect that requires attention. Although Wang et al[3] demonstrated significant improvements in anxiety symptoms and tic severity in the immediate post-treatment period, the sustainability of these gains over extended periods remains uncertain. The lack of long-term follow-up data in the study precludes an understanding of whether the benefits of the combination modality are sustained or if patients relapse over time. Further studies incorporating longer follow-up periods are required to assess the longevity of treatment outcomes.

Additionally, the study did not extensively explore the potential moderating effects of genetic, environmental, and neurobiological factors on the response to behavioral interventions. Given the complicated etiology of TS[8], the interplay between these factors may significantly influence the effectiveness of CBT and HRT. Future research should aim to uncover how these factors interact with behavioral therapies to achieve optimal outcomes for different subgroups of TS patients, potentially paving the way for more personalized and targeted treatment strategies.

In addition, while Wang et al's study[3] indicated that CBT and HRT can be effective for managing anxiety disorders in TS patients, it does not comprehensively address the broader spectrum of psychological comorbidities often accompanying TS. Depression and OCD are significant psychological concerns for TS patients that may not be adequately addressed with CBT alone[9]. A systematic review and meta-analysis has shown that CBT, particularly exposure and ERP, is effective in managing OCD symptoms[10]. CBT's focus on reframing negative thought patterns and fostering adaptive coping strategies has shown promise in alleviating depressive symptoms[11]. Although HRT is predominantly used for tic reduction, its focus on increasing awareness and reducing maladaptive behaviors may indirectly support improved mood and reduced distress, warranting further investigation into its broader psychological benefits. This highlights the need for research that explores the role of CBT and other behavioral therapies in the treatment of OCD and depression in TS patients, as well as the potential benefits of integrating these therapies with pharmacological treatments and neurobiological interventions.

In view of the above-mentioned deficiencies, it is of importance that the field of treatment of TS undergoes further development and innovation. This process should be grounded in robust evidence and interdisciplinary knowledge, with the aim of refining current behavioral interventions. This entails not only extending the scope of clinical trials to encompass diverse populations and longer follow-up periods, but also fostering collaborations between behavioral psychologists, neurologists, and rehabilitators. Such collaborations would facilitate a deeper understanding of the multifaceted nature of TS.

Emerging digital interventions, such as internet-based CBT and ERP, show promise in sustaining long-term benefits for tics in children and adolescents[12]. Internet-delivered behavioral therapies can be integrated into routine healthcare systems to improve treatment accessibility for children with TS. Khan’s study highlights that digitally delivered therapies, including therapist- or parent-guided CBT, are effective in reducing tic severity and enhancing long-term functional outcomes. These approaches demonstrate comparable efficacy to traditional face-to-face therapies while offering the advantages of increased accessibility and cost-effectiveness[13]. CBIT has also been successfully adapted to internet-based platforms, enabling broader reach, overcoming treatment barriers, and supporting long-term adherence and symptom management[14]. Moreover, a recent study by Andrén et al[15] demonstrated that internet-delivered ERP could be used to enhance access to behavioral therapies in TS patients and showed significant improvements in tic severity. However, challenges remain in implementing these interventions across diverse populations. Pringsheim et al[16] had discussed the meaningful progress being made in internet-based CBT for tic treatment, suggesting that despite some limitations, such as not reaching YGTSS-TTS score change as the primary outcome, internet-delivered administration has proven to be a successful method of delivering CBIT to TS patients. Future research should focus on scalability, feasibility in resource-limited settings, and strategies to address disparities in digital literacy and access. Emphasizing culturally tailored content, user-friendly designs, and cost-effective delivery models could further enhance the global reach of internet-based interventions. The integration of these innovations into telehealth systems could transform the landscape of behavioral therapy for TS, addressing the unmet needs of under-resourced and underserved communities[17].

CONCLUSION

In conclusion, the current landscape of behavioral interventions for TS is characterized by a robust evidence base for the combination of CBT and HRT. These therapies have proven effective in managing both the motor and vocal tics associated with TS, as well as the psychological comorbidities that often exacerbate the condition. While strides have been made, the field continues to evolve, with technology playing an increasingly significant role in enhancing access and delivery. Additionally, the importance of neurodiversity can also be seen in evaluating the efficacy of behavioral therapy for TS[18]. Our editorial provides novelty ideas and directions for further study on extending the scope of clinical trials to encompass diverse populations and longer follow-up periods and fostering collaborations between behavioral psychologists, neurologists, and rehabilitators. Future research should focus on optimizing these interventions to ensure their efficacy across diverse populations and explore the potential for combined therapeutic approaches to better serve the complex needs of TS patients.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Psychiatry

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade A, Grade A, Grade A, Grade A

Novelty: Grade A, Grade A, Grade A, Grade B

Creativity or Innovation: Grade A, Grade A, Grade B, Grade B

Scientific Significance: Grade A, Grade A, Grade A, Grade B

P-Reviewer: Wang YL; Wang W S-Editor: Li L L-Editor: A P-Editor: Zheng XM

References
1.  Johnson KA, Worbe Y, Foote KD, Butson CR, Gunduz A, Okun MS. Tourette syndrome: clinical features, pathophysiology, and treatment. Lancet Neurol. 2023;22:147-158.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in RCA: 49]  [Article Influence: 24.5]  [Reference Citation Analysis (0)]
2.  Andrén P, Jakubovski E, Murphy TL, Woitecki K, Tarnok Z, Zimmerman-Brenner S, van de Griendt J, Debes NM, Viefhaus P, Robinson S, Roessner V, Ganos C, Szejko N, Müller-Vahl KR, Cath D, Hartmann A, Verdellen C. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry. 2022;31:403-423.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in RCA: 65]  [Article Influence: 21.7]  [Reference Citation Analysis (0)]
3.  Wang YZ, Zhang X, Han XM. Efficacy of cognitive-behavioral therapy combined with habit reversal training on anxiety disorders in children with Tourette's syndrome. World J Psychiatry. 2024;14:999-1008.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (5)]
4.  Yu L, Li Y, Zhang J, Yan C, Wen F, Yan J, Wang F, Liu J, Cui Y. The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials. Expert Rev Neurother. 2020;20:1189-1196.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in RCA: 3]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
5.  Chen CW, Wang HS, Chang HJ, Hsueh CW. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome: A randomized controlled trial. J Adv Nurs. 2020;76:903-915.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in RCA: 16]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
6.  Hwang GC, Tillberg CS, Scahill L. Habit reversal training for children with tourette syndrome: update and review. J Child Adolesc Psychiatr Nurs. 2012;25:178-183.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in RCA: 16]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
7.  Frey J, Malaty IA. Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. Curr Neurol Neurosci Rep. 2022;22:123-142.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in RCA: 11]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
8.  Fichna JP, Borczyk M, Piechota M, Korostynski M, Zekanowski C, Janik P. Genomic variants and inferred biological processes in multiplex families with Tourette syndrome. J Psychiatry Neurosci. 2023;48:E179-E189.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
9.  Groth C, Mol Debes N, Rask CU, Lange T, Skov L. Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study. J Am Acad Child Adolesc Psychiatry. 2017;56:304-312.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 104]  [Cited by in RCA: 129]  [Article Influence: 16.1]  [Reference Citation Analysis (0)]
10.  Reid JE, Laws KR, Drummond L, Vismara M, Grancini B, Mpavaenda D, Fineberg NA. Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials. Compr Psychiatry. 2021;106:152223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in RCA: 85]  [Article Influence: 21.3]  [Reference Citation Analysis (0)]
11.  Chen H, He Q, Wang M, Wang X, Pu C, Li S, Li M. Effectiveness of CBT and its modifications for prevention of relapse/recurrence in depression: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord. 2022;319:469-481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
12.  Hollis C, Hall CL, Jones R, Marston L, Novere ML, Hunter R, Brown BJ, Sanderson C, Andrén P, Bennett SD, Chamberlain LR, Davies EB, Evans A, Kouzoupi N, McKenzie C, Heyman I, Khan K, Kilgariff J, Glazebrook C, Mataix-Cols D, Murphy T, Serlachius E, Murray E. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Lancet Psychiatry. 2021;8:871-882.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in RCA: 16]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
13.  Khan K, Hollis C, Murphy T, Hall CL. Digital and remote behavioral therapies for treating tic disorders: Recent advances and next steps. Front Psychiatry. 2022;13:928487.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
14.  Rachamim L, Zimmerman-Brenner S, Rachamim O, Mualem H, Zingboim N, Rotstein M. Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders: a feasibility and effectiveness study with 6 month-follow-up. Eur Child Adolesc Psychiatry. 2022;31:275-287.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in RCA: 14]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
15.  Andrén P, Holmsved M, Ringberg H, Wachtmeister V, Isomura K, Aspvall K, Lenhard F, Hall CL, Davies EB, Murphy T, Hollis C, Sampaio F, Feldman I, Bottai M, Serlachius E, Andersson E, Fernández de la Cruz L, Mataix-Cols D. Therapist-Supported Internet-Delivered Exposure and Response Prevention for Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2022;5:e2225614.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Reference Citation Analysis (0)]
16.  Pringsheim T, Piacentini J. Internet-Based Cognitive Behavioral Therapy for Tourette Syndrome-Meaningfully Improving Access to Behavioral Therapy for Tics. JAMA Netw Open. 2022;5:e2225627.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
17.  Iacobucci G. Tics and Tourette syndrome: Digital therapies could reduce severity of symptoms, says NICE. BMJ. 2024;387:q2570.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
18.  Graber A, Rizzo M. Tourette Syndrome: A Catalyst for Operationalizing Neurodiversity. Neurology. 2024;103:e209572.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]